Effects of Hydrotherapy in Children With Cerebral Palsy
Launched by GAZIOSMANPASA RESEARCH AND EDUCATION HOSPITAL · Mar 26, 2025
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of hydrotherapy, which is therapy conducted in water, on children with cerebral palsy. The main focus is to see if hydrotherapy can help improve balance and motor control in these children. The study is currently looking for participants aged 4 to 18 who have been diagnosed with cerebral palsy by a doctor and can cooperate with physiotherapy activities.
To participate, children need to have a Gross Motor Function Classification System (GMFCS) level between 1 and 4, which means they have some ability to move but may still need assistance. Unfortunately, children with severe forms of cerebral palsy (GMFCS level 5), certain medical conditions, or those who have had recent surgeries or infections are not eligible. If chosen for the study, participants can expect to take part in hydrotherapy sessions and assessments to track their progress. This trial aims to understand whether this water-based therapy could be beneficial for improving movement and balance in children with cerebral palsy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with Cerebral Palsy by a specialist physician
- • Aged between 4-18 years
- • Cooperative with physiotherapy applications
- • Gross Motor Function Classification System (GMFCS) levels 1-4
- • Willing to participate in the study and undergo assessments
- Exclusion Criteria:
- • Mental retardation or insufficient cognitive function to comply with study assessments
- • GMFCS level 5
- • Presence of an intrathecal baclofen pump for spasticity treatment or history of soft tissue and/or bone surgery
- • Active infection or localized skin infection at the injection site
- • History of active seizures
- • Presence of contractures
- • Serious systemic disease that may prevent exercise participation
- • Injury and/or surgery within the last 6 months
- • Botulinum toxin injection within the last 6 months
- • Contraindications to hydrotherapy, including severe fear of water, behavioral problems, shortness of breath at rest, infection, incontinence, known chlorine allergy, open wounds, acute systemic illness, epilepsy, tracheostomy, permanent drains, immunodeficiency.
About Gaziosmanpasa Research And Education Hospital
Gaziosmanpasa Research and Education Hospital is a leading healthcare institution dedicated to advancing medical research and education. With a commitment to innovative clinical practices, the hospital serves as a hub for clinical trials aimed at improving patient outcomes and enhancing therapeutic options. The institution fosters collaboration among multidisciplinary teams, integrating cutting-edge research with exceptional patient care. By prioritizing ethical standards and regulatory compliance, Gaziosmanpasa Research and Education Hospital is poised to contribute significantly to the field of medical science and the development of new treatment modalities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Gaziosmanpasa, Turkey
Patients applied
Trial Officials
Ebru Yılmaz Yalçınkaya
Study Director
Gaziosmanpasa Research and Education Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported